RenovoRx, Inc.
Ticker: 1574094
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 0.91+62.5% | 0.56+107.4% | 0.27-35.7% | 0.42+110.0% | 0.20 |
| Total Income | 0.91+62.5% | 0.56+107.4% | 0.27-35.7% | 0.42+110.0% | 0.20 |
| EXPENSES | |||||
| Expenditure | 4.26+5.7% | 4.03+16.1% | 3.47+11.9% | 3.10-6.3% | 3.31 |
| Tax | — | 0.00 | — | — | 0.00 |
| PROFIT | |||||
| Net Profit | -2.91+17.3% | -3.52-21.0% | -2.91-0.3% | -2.90-19.8% | -2.42 |
| KEY METRICS | |||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.06+33.3% | -0.09-12.5% | -0.08+0.0% | -0.08+0.0% | -0.08 |
Corporate Events
Board MeetingRNXT
202630Jun
Board Meeting
Annual meeting of stockholders to elect directors, approve a…
SEC Filing ↗